Khosla Ventures Leads $300 Million Funding Round for Even Healthcare, Aiming to Reshape Indian Hospital Economics

Khosla Ventures has spearheaded a new financing round that lifts the valuation of Indian health‑tech firm Even Healthcare to $300 million, signaling a major vote of confidence in the company’s plan to broaden its hospital network across the country.

Founded a few years ago, Even Healthcare offers a technology platform that seeks to streamline the financial and operational side of hospitals, promising to lower costs while improving patient outcomes. The startup combines data analytics, procurement tools and digital care pathways to address long‑standing inefficiencies in India’s fragmented health‑care system.

The Indian hospital sector has been grappling with rising expenses, uneven quality standards and a shortage of capital for modernization. Public and private providers alike face pressure to deliver affordable services without compromising care, a challenge that has attracted interest from investors looking to back scalable solutions.

Even’s suite of services tackles these issues by centralising supply‑chain management, automating billing processes and enabling remote monitoring of patients. By providing hospitals with a unified dashboard for clinical and financial metrics, the platform aims to reduce waste, negotiate better pricing for consumables and support evidence‑based treatment protocols.

The latest round, led by Khosla Ventures, did not disclose the exact amount raised, but the involvement of the Silicon Valley firm—known for backing disruptive health‑tech ventures—underscores the strategic importance of the Indian market. Existing backers are also participating, reinforcing confidence in Even’s growth trajectory.

Company executives say the capital will be directed toward opening new facilities in tier‑2 and tier‑3 cities, expanding the technology stack, and recruiting clinical and engineering talent to accelerate product development. The funding is also expected to fuel partnerships with regional hospital groups eager to adopt data‑driven management tools.

Industry analysts note that the infusion of venture capital could intensify competition among health‑tech providers vying for a share of India’s $150‑billion hospital spend. If Even can demonstrate measurable cost savings and quality improvements, it may set a benchmark that prompts larger, established players to adopt similar digital solutions.

Regulatory bodies in India have recently emphasized the need for affordable, high‑quality health care, launching initiatives that encourage technology adoption in hospitals. This policy backdrop could create a favorable environment for Even’s expansion, provided the company navigates compliance and data‑privacy requirements effectively.

Looking ahead, Even Healthcare plans to roll out its expanded network over the next 12‑18 months, with the goal of establishing a replicable model that other regions can emulate. Success could reshape how hospitals manage resources in India, potentially delivering lower costs for patients and a more sustainable business model for providers.